High density lipoprotein downregulates angiotensin II type 1 receptor and inhibits angiotensin II-induced cardiac hypertrophy

Li Lin(Chinese Academy of Medical Sciences & Peking Union Medical College), Yunzeng Zou(Fudan University), Lei Li(Fudan University), Guoping Zhang(Shandong Academy of Agricultural Sciences), Junbo Ge(Shanghai Medical College of Fudan University), Hui Gong(Ningbo University), Guoliang Jiang(Huangshan University), GE Jing-yi(Fudan University), Yong Ye(Sun Yat-sen University), Ning Zhou(Tongji Hospital)
Biochemical and Biophysical Research Communications
November 20, 2010
10.1016/j.bbrc.2010.11.037
Cited by 23

Related Papers

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism
|European Heart Journal|2018|435
Guiding Principles for Chronic Total Occlusion Percutaneous Coronary Intervention
|Circulation|2019|433
Worldwide Ethnic Distribution of the G Protein β3 Subunit 825T Allele and Its Association with Obesity in Caucasian, Chinese, and Black African Individuals
|Journal of the American Society of Nephrology|1999|334
Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial
|The Lancet Diabetes & Endocrinology|2017|325